Skip to content
Home/Companies/Biotech/Cube
CU

Cube

Biotech·Germany·Active·5yr hold

Cube is a software company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Cube?

Cube is currently owned by ARCHIMED through MED III (2021 vintage), since 2021. Across its history, Cube has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

ARCHIMED
Most recent investor
ARCHIMED
MED III · 2021 · Buyout
2 ownership periods · full history below

Key facts

HQUK
SectorSoftware

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by ARCHIMED since 2021.
Co-invest · 2 holders · 2021 · present
ARCHIMED
ARCHIMEDActive
2021 · present · MED III · 2021 · Buyout
MOIC
–
Bregal Milestone
Bregal MilestoneExited 2024
2022 · 2024 · Bregal Milestone Fund I · 2018 · Growth
Trade Sale · to
MOIC
–

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Active
PharmaUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings